Senokot-s

Senokot-s
SPL v11
SPL
SPL Set ID c24cdc5e-62e0-41a6-8afb-512202a569f4
Route
ORAL
Published
Effective Date 2023-12-26
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Sennosides (8.6 mg) Docusate (50 mg)
Inactive Ingredients
Croscarmellose Sodium Calcium Phosphate, Dibasic, Anhydrous Fd&c Yellow No. 5 Fd&c Yellow No. 6 Hypromellose, Unspecified Magnesium Stearate Maltodextrin Cellulose, Microcrystalline Mineral Oil Polyethylene Glycol, Unspecified Sodium Benzoate Sodium Lauryl Sulfate Starch, Corn Stearic Acid Talc Titanium Dioxide Triacetin

Identifiers & Packaging

Pill Appearance
Imprint: P Shape: round Color: orange Size: 10 mm Score: 1
Marketing Status
OTC MONOGRAPH DRUG Active Since 1974-10-01

Description

Drug Facts


Medication Information

Warnings and Precautions

Warnings

Indications and Usage

Drug Facts

Dosage and Administration

Directions

  • take preferably at bedtime or as directed by a doctor
age startingdosage maximumdosage
adults and children

12 years of age and over
2 tablets oncea day 4 tablets twicea day
children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day
children under 2 years ask a doctor ask a doctor
Dosage Forms and Strengths

Other information

  • each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
  • store at 25°C (77°F); excursions permitted between 15°-30°C(59°-86°F)
Description

Drug Facts

Section 50565-1

Keep out of reachof children.

In case ofoverdose, get medical help or contact a Poison Control Center rightaway.

Section 50566-9

Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.

Section 50567-7

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours
Section 50569-3

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues overa period of 2 weeks
Section 50570-1

Do not use

  • if you are now taking mineral oil, unless directed by adoctor
  • laxative products for longer than 1 week unless directedby a doctor
Section 51727-6

Inactive ingredients

Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin

©2020

Avrio Health L.P.

A1023

Section 51945-4

Senokot-S 60 Tablets Label

NDC: 67618-310-60

Senokot-S 60 Tablets Leaflet

NDC: 67618-310-60

Senokot-S 60 Tablets Carton

NDC: 67618-310-60

Senokot-S 10 Tablets Carton

NDC: 67618-310-01

Section 53414-9

If pregnant or breast-feeding, ask a health professional before use.

Section 55105-1

Purpose

Stool softener

Laxative

Section 55106-9

Active ingredients (in each tablet)

Docusate sodium         50mg

Sennosides                      8.6mg


Structured Label Content

Indications and Usage (34067-9)

Drug Facts

Dosage and Administration (34068-7)

Directions

  • take preferably at bedtime or as directed by a doctor
age startingdosage maximumdosage
adults and children

12 years of age and over
2 tablets oncea day 4 tablets twicea day
children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day
children under 2 years ask a doctor ask a doctor
Dosage Forms and Strengths (34069-5)

Other information

  • each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
  • store at 25°C (77°F); excursions permitted between 15°-30°C(59°-86°F)
Warnings and Precautions (34071-1)

Warnings

Section 50565-1 (50565-1)

Keep out of reachof children.

In case ofoverdose, get medical help or contact a Poison Control Center rightaway.

Section 50566-9 (50566-9)

Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.

Section 50567-7 (50567-7)

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours
Section 50569-3 (50569-3)

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues overa period of 2 weeks
Section 50570-1 (50570-1)

Do not use

  • if you are now taking mineral oil, unless directed by adoctor
  • laxative products for longer than 1 week unless directedby a doctor
Section 51727-6 (51727-6)

Inactive ingredients

Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin

©2020

Avrio Health L.P.

A1023

Section 51945-4 (51945-4)

Senokot-S 60 Tablets Label

NDC: 67618-310-60

Senokot-S 60 Tablets Leaflet

NDC: 67618-310-60

Senokot-S 60 Tablets Carton

NDC: 67618-310-60

Senokot-S 10 Tablets Carton

NDC: 67618-310-01

Section 53414-9 (53414-9)

If pregnant or breast-feeding, ask a health professional before use.

Section 55105-1 (55105-1)

Purpose

Stool softener

Laxative

Section 55106-9 (55106-9)

Active ingredients (in each tablet)

Docusate sodium         50mg

Sennosides                      8.6mg


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)